Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
04/2000
04/04/2000US6046204 Treatment of immunosuppressive, autoimmune, inflammatory, proliferative and hyperproliferative diseases including cancer, and of cutaneous manifestations of immunologically mediated diseases, for example rheumatoid arthritis, lupus
04/04/2000US6046195 Useful in the treatment or prevention of pain, inflammation, migraine, emesis and postherpetic neuralgia
04/04/2000US6046022 Methods and compositions employing red rice fermentation products
04/04/2000CA2127331C Motilin-like polypeptides that inhibit gastrointestinal motor activity
04/04/2000CA2107432C Quaternary basic amides, method of preparing them and pharmaceutical compositions in which they are present
03/2000
03/30/2000WO2000017371A1 Polynucleotide constructs and uses thereof
03/30/2000WO2000017357A1 Methods and compositions relating to egf-repeat-containing polypeptides
03/30/2000WO2000017354A1 Human isre-binding protein
03/30/2000WO2000017222A1 31 human secreted proteins
03/30/2000WO2000017204A1 INHIBITORS OF p38
03/30/2000WO2000017203A1 Pyrrolopyrimidines as protein kinase inhibitors
03/30/2000WO2000017202A1 4-aminopyrrolopyrimidines as kinase inhibitors
03/30/2000WO2000017200A1 Tetrahydropyridoethers
03/30/2000WO2000017192A1 2-arylalkylthio -imidazoles, 2-arylalkenyl -thio -imidazoles and 2-arylalkinyl -thio -imidazoles as anti -inflammatory substances and substances inhibiting the release of cytokine
03/30/2000WO2000017191A2 N-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them
03/30/2000WO2000017190A2 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
03/30/2000WO2000017173A1 Benzoxazine and benzothiazine derivatives and their use in medicines
03/30/2000WO2000017167A1 Aminoalkyl-3,4-dihydroquinoline derivates as no-synthase inhibitors
03/30/2000WO2000017143A1 Derivatives of phenantrene for medicinal use and a process for their preparation
03/30/2000WO2000017133A2 Lta4 hydrolase inhibitors
03/30/2000WO2000016789A1 Method for removing undesirable toxic alkaloids from plants or vegetable preparations
03/30/2000WO2000016780A1 Optimized use of 6-mercaptopurine drug in the treatment of immune-mediated gastrointestinal disorders
03/30/2000WO2000016779A1 Antiviral combinations comprising lamivudine and abacavir
03/30/2000WO2000016765A1 Method and composition for treatment of inflammatory bowel disease
03/30/2000WO2000009711A8 ISOLATED AND PURIFIED HUMAN SOLUBLE GUANYLYLCYCLASE α1/β1 (hsGCα1/β1)
03/30/2000WO1999066918A9 Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor
03/30/2000WO1999065449A3 INHIBITORS OF TRANSCRIPTION FACTOR NF-λB
03/30/2000WO1998053846A9 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
03/30/2000DE19849107A1 Verfahren zur Entfernung von unerwünschten, toxischen Alkaloiden aus Pflanzen oder aus pflanzlichen Zubereitungen A process for the removal of undesired toxic alkaloids from plants or from plant preparations
03/30/2000DE19845830A1 Aminoalkyl-3,4-dihydrochinolin-Derivate und ihre Verwendung in Arzneimitteln Aminoalkyl-3,4-dihydroquinoline derivatives and their use in medicaments
03/30/2000DE19843413C1 Neue Salzform von Pantoprazol New salt form of pantoprazole
03/30/2000DE19842833A1 2-Arylalkylthio-imidazole, 2-Arylalkenylthio-imidazole und 2-Arylalkinylthio-imidazole als Entzündungs-Hemmstoffe und Hemmstoffe der Cytokin-Freisetzung 2-arylalkylthio-imidazole, 2-Arylalkenylthio-imidazole and 2-Arylalkinylthio-imidazoles as inflammatory inhibitors and inhibitors of cytokine release
03/30/2000CA2344657A1 Human isre-binding protein
03/30/2000CA2344438A1 Method and composition for treatment of inflammatory bowel disease
03/30/2000CA2344262A1 4-aminopyrrolopyrimidines as kinase inhibitors
03/30/2000CA2344251A1 Tetrahydropyridoethers
03/30/2000CA2344249A1 Pyrrolopyrimidines as protein kinase inhibitors
03/30/2000CA2344224A1 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
03/30/2000CA2344223A1 N-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them
03/30/2000CA2344100A1 31 human secreted proteins
03/30/2000CA2343360A1 Human cytoskeleton associated proteins
03/30/2000CA2343353A1 Methods and compositions relating to egf-repeat-containing polypeptides
03/30/2000CA2341170A1 Benzoxazine and benzothiazine derivatives and their use in medicines
03/30/2000CA2340990A1 Aminoalkyl-3,4-dihydroquinoline derivates as no-synthase inhibitors
03/29/2000EP0988377A1 Zinc finger protein derivatives and methods therefor
03/29/2000EP0988320A1 Cyclic crf agonists
03/29/2000EP0988298A1 Coumarin derivatives, methods of preparation and application as medicines
03/29/2000EP0988035A1 Caspases and apoptosis
03/29/2000EP0988033A1 Use of dichlorobenzyl alcohol for preparing a preparation for topical treatment of inflammation and a preparation containing dichlorobenzyl alcohol
03/29/2000EP0988028A1 Therapeutically active compositions
03/29/2000EP0801554A4 Formulations and methods for reducing skin irritation
03/29/2000EP0717739B1 1,4-Benzodioxane derivatives having affinity for D2 receptors and utility in the treatment of psychoses
03/29/2000CN1248968A Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of MIP-1-alpha binding to its CCRI receptor
03/29/2000CN1248966A Aminobenzophenones as inhibitors of interleukin and TNF
03/29/2000CN1248918A Liver protection or treatment agents comprising astatic acid derivatives as the active component
03/29/2000CN1248583A Caryophyllin acid sodium and application in pharmacy thereof
03/29/2000CN1248469A Powder medicine for treating hepatitis B
03/29/2000CN1248462A Ganhuo mixture medicine for hepatosis
03/29/2000CN1248461A Health care oral liquid for old people and preparation process thereof
03/29/2000CN1050839C Sulfonylamino pyrimidines compounds, medicinal composition containing same, its preparation process and use
03/29/2000CN1050835C 1,5-benzodiazepine derivatives and its preparation process and use in medicine
03/28/2000US6043389 Hydroxy and ether-containing oxyalkylene esters and uses thereof
03/28/2000US6043373 Heterocycle-fused thiazole derivatives
03/28/2000US6043371 Reacting 3,5-dimethyl-2-methoxypyran-4-one compound with ammonia
03/28/2000US6043352 Increased hybridization binding affinity and nuclease resistance
03/28/2000US6043243 Pyrrolidine derivative, anti-ulcer drug, and antibacterial drug
03/28/2000US6043239 Heterocyclic compounds
03/28/2000US6043233 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
03/28/2000US6043229 Increased n-butyrate production will diminish the development of colon diseases notably of colon cancer.
03/28/2000US6043054 Polynucleotides encoding a novel GABA BP polypeptide
03/28/2000US6042823 Ingesting an enzyme selected from amylase and invertase capable of acting in the living body together with a food material containing a substrate for forming oligosaccharide to prevent weight gain, diabetes, gastrointestinal disorders
03/28/2000US6042822 Mixture of alpha-interferon-conjugate positional isomers comprises an alpha-interferon covalently conjugated to a non-antigenic alkyl terminated polyalkylene oxide at a histidine residue on alpha interferon
03/28/2000CA2126086C Imidazoylalkyl substituted with a six membered nitrogen containing heterocyclic ring
03/28/2000CA2024964C N-azabicyclo{3.3.0|octane amides of aromatic acids
03/23/2000WO2000015797A2 Compositions and methods for the treatment of immune related diseases
03/23/2000WO2000015793A2 Human gpcr proteins
03/23/2000WO2000015775A1 Rnase p polypeptides
03/23/2000WO2000015770A2 Human serine/threonine protein kinases
03/23/2000WO2000015659A2 Stomach polypeptide zsig28
03/23/2000WO2000015639A1 Carboline derivatives as cgmp phosphodiesterase inhibitors
03/23/2000WO2000015614A1 Novel compounds
03/23/2000WO2000015611A1 Branched alkyl pyrrolidine-3-carboxylic acids
03/23/2000WO2000015609A1 Azetidine derivatives, preparation and medicines containing them
03/23/2000WO2000015245A2 Stable liquid formulations of botulinum toxin
03/23/2000WO2000015232A1 Taurolidine and/or taurultam against infectious ulcer or gastritis
03/23/2000WO2000015228A1 Combinations of tetracyclic cyclic gmp-specific phosphodiesterase inhibitors with further therapeutic agents
03/23/2000WO2000015215A1 Composition containing cinnamic acid derivatives for preventing or treating elevated blood lipid level-related diseases
03/23/2000WO2000015208A2 New use of immunosupressants for mmp-mediated diseases
03/23/2000WO2000015195A1 Quick release pharmaceutical compositions of drug substances
03/23/2000WO2000015047A1 Composition containing neohesperidin dihydrochalcone for preventing or treating elevated blood lipid and glucose level-related diseases
03/23/2000WO2000015044A1 Composition containing natural phenolic compounds for preventing or treating elevated blood lipid level-related diseases
03/23/2000WO2000008013A3 2-substituted-1-piperidyl benzimidazole compounds as orl1-receptor agonists
03/23/2000WO1999066948A3 Use of a dipeptide for stimulating repair processes
03/23/2000DE19844291A1 New aminoalkylaminoalkyl-substituted benzoxazines or benzothiazines, are nitrogen monoxide synthase inhibitors useful for treating neurodegenerative, inflammatory, autoimmune or cardiovascular disease
03/23/2000CA2344401A1 Composition containing natural phenolic compounds for preventing or treating elevated blood lipid level-related diseases
03/23/2000CA2344322A1 Composition containing neohesperidin dihydrochalcone for preventing or treating elevated blood lipid and glucose level-related diseases
03/23/2000CA2343578A1 Human serine/threonine protein kinases
03/23/2000CA2343001A1 Stomach polypeptide zsig28
03/23/2000CA2342833A1 Human gpcr proteins
03/23/2000CA2342243A1 Stable liquid formulations of botulinum toxin
1 ... 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 1105 1106 1107 1108 ... 1258